Olema Pharmaceuticals, Inc. OLMA Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Olema Pharmaceuticals, Inc.'s financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Olema Pharmaceuticals, Inc.'s financing cash flow?
- Olema Pharmaceuticals, Inc. (OLMA) reported financing cash flow of $45.7M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s financing cash flow changed year-over-year?
- Olema Pharmaceuticals, Inc.'s financing cash flow increased by 20487.4% year-over-year, from $222K to $45.7M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s financing cash flow?
- Over 3 years (2022 to 2025), Olema Pharmaceuticals, Inc.'s financing cash flow has grown at a 662.8% compound annual growth rate (CAGR), from $476K to $211.3M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.